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Abstract
Background: The gastrointestinal tract microbiota (GTM) of mammals is a complex microbial consortium, the composition
and activities of which influences mucosal development, immunity, nutrition and drug metabolism. It remains unclear
whether the composition of the dominant GTM is conserved within animals of the same strain and whether stable GTMs are
selected for by host-specific factors or dictated by environmental variables.
Methodology/Principal Findings: The GTM composition of six highly inbred, genetically distinct strains of mouse (C3H, C57,
GFEC, CD1, CBA nu/nu and SCID) was profiled using eubacterial –specific PCR-DGGE and quantitative PCR of feces. Animals
exhibited strain-specific fecal eubacterial profiles that were highly stable (c. .95% concordance over 26 months for C57).
Analyses of mice that had been relocated before and after maturity indicated marked, reproducible changes in fecal
consortia and that occurred only in young animals. Implantation of a female BDF1 mouse with genetically distinct (C57 and
Agoutie) embryos produced highly similar GTM profiles (c. 95% concordance) between mother and offspring, regardless of
offspring strain, which was also reflected in urinary metabolite profiles. Marked institution-specific GTM profiles were
apparent in C3H mice raised in two different research institutions.
Conclusion/Significance: Strain-specific data were suggestive of genetic determination of the composition and activities of
intestinal symbiotic consortia. However, relocation studies and uterine implantation demonstrated the dominance of
environmental influences on the GTM. This was manifested in large variations between isogenic adult mice reared in
different research institutions.
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Introduction
The gastrointestinal tract microbiota (GTM) of mammals
supports a microbial ecosystem, which at up to 10
14 cells,
outnumbers somatic cells by at least one order of magnitude.
The interplay between GTM and host is complex, with diverse
positive and potentially negative implications for host health in
the short and longer-term. Intestinal colonization-resistance for
example, may reduce the incidence and severity of intestinal
infections through limitationo fa d h e s i o ns i t e sa n dg r o w t h
substrates and by the accumulation of inhibitory metabolites
[1]. It is also clear that the GTM plays an important role in the
development of the immune system from birth onwards [2] and
in gastrointestinal mucosal development [3,4,5,6]. The compo-
sition and metabolism of the GTM affects other fundamental
host processes including drug metabolism, where the absorption
and bioavailability of drugs and their metabolites may be altered
through prokaryotic biotransforma t i o n[ 7 , 8 ] .F u r t h e r m o r e ,h o s t
nutritional status may be markedly influenced by the compo-
sition and activities of the GTM since it is apparent that the
ratio of Bacteroidetes to Firmicutes is decreased in obese
individuals and genetically obese mice harbour an ‘‘obese
microbiome’’, with a transferable elevated capacity for energy
sequestration [9].
Several recent investigations have demonstrated considerable
integration of prokaryotic and mammalian metabolism with
respect to polysaccharide metabolism [10,11,12] and other host
processes [13,14] which is strong evidence for co-evolution of host
and microbiota. The GTM can therefore be viewed as a versatile
prokaryotic metabolic organ [10,11,15].
Evidence is emerging to suggest a considerable degree of
individuality and temporal stability within human and murine
GTMs. Various studies using PCR-DGGE and cluster analyses
of human [16,17] and murine GTMs [18,19] for example, have
indicated the occurrence of host-specific predominant mucosa-
associated and luminal bacterial community profiles.
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stability of individual-specific GTMs remain unclear. It is possible
that, through the inherent stability and colonisation resistance of
complex microbial climax communities, GTMs may maintain
specific profiles through microbial competition, particularly during
colonization [20]. However, since the microbiota exists in close
proximity with mammalian tissues, there are many host factors
host that may also influence the diversity, richness and stability of
the microbiota. Mammalian tissues can sense and coordinate
appropriate immunological responses to symbiotic and pathogenic
bacteria using Toll-like and Nod-like receptors (TLRs and NLRs)
[21,22]. The involvement of TLRs and NLRs in gut homeostasis
has been additionally suggested by the presence of polymorphisms
in TLR and NOD2 genes in patients with inflammatory bowel
disease [23]. Other variables known to broadly influence the
composition of the GTM include age, where distinct microbiota
profiles have been associated with the young and aged individuals
[24]; diet which has a measurable but apparently limited influence
[20,25], the use of antibiotics [26] and other drugs [27] and
‘‘lifestyle’’ [28].
Despite a considerable increase in interest in the function and
natural history of the GTM and in strategies for its therapeutic
compositional manipulation, insight into the broad contributions
of host genetics versus environmental factors upon development,
composition and maintenance of the GTM remains incomplete
and there are relatively few reports addressing this in the literature,
probably due to difficulties associated with experimentally
separating environmental from genetic influences.
The possible involvement of host genotype, particularly as it
relates to immuno-phenotype, has been frequently postulated as a
major influence on GTM composition and stability although this
has been difficult to prove. For example, recent studies have
investigated the possible correlation between host genetic
relatedness and fecal microbial profiles in human adult twins.
Zoetendal et al. [6] used PCR-DGGE-based fecal profiling to
demonstrate a correlation between overall genetic relatedness and
similarity indices of abundant fecal microbiota 16S rRNA
sequence variants. Similarly, Stewart et al. [29] profiled fecal
bacterial populations and calculated of the degree of similarity in
the predominant fecal microbiota of identical twin pairs, fraternal
twin pairs and unrelated, paired controls. Since the highest levels
of similarity was found in genetically identical twins, with
significant differences evident between the identical and fraternal
twins, the authors concluded host genetics influenced the
composition of the dominant eubacterial population in children.
Dicksved et al. [30] investigated the GTM profiles in 10
monozygotic twin pairs where one or both had Crohn’s disease
and eight healthy twin pairs and showed that GTMs were more
similar between healthy twins than between twins with CD,
especially when these were discordant for the disease. The authors
concluded that ‘‘genetics and/or environmental exposure during
childhood, in part, determine the gut microbial composition’’.
Despite the obvious usefulness of studies using human twins,
they do not present a definitive means of separating genetic from
environmental influences due to the frequent confounding
influence of close social and familial contact. In the Stewart study
for example [29], the genetically-related volunteers were living in
the same home environment at the time of sample collection.
Further evidence for the importance of host genetics in the
determination of host-microbe interaction is provided by a recent
study by Khachatryan et al. [31] who profiled the GTMs of
subjects with the auto-inflammatory disorder, familial Mediterra-
nean fever and showed that significant changes in GTMs occurred
during inflammatory episodes according to sequence analyses and
FISH. Importantly however, the allele-carrier status of individuals
for the genes associated with this disease was a significant
determinant of GTM composition, even in remission.
Whilst the environment represents a continuous microbial
challenge to the GTM, it is believed that external influences upon
the microbial composition of the GTM are greatest in nascent
microbiotas, following birth. In new-borne mammals, the sterile
intestine represents a readily colonisable environment, being
subject to microbial immigration from sources such as the birth
canal and faecal material [32]. Bacteria associated with breast milk
have been shown to represent a source of bifidobacteria for infant
GTMs [33] and an extensive metagnomic study of human infants
has indicated compositional and temporal patterns of the microbial
communities which vary widely between individuals, leading to the
development of a characteristic adult GTM profile after c. 12
months [34]. In the same study, temporal patterns of consortial
development between twins were ‘‘strikingly parallel’’; an observa-
tion used to support the hypothesis that ‘‘incidental environmental
exposures’’ are responsible for individualised GTMs.
Other environmental variables may significantly influence the
composition of the GTM, including antibiotic use where it has for
example been shown that oral ciprofloxacin dosing alters the
abundance of approximately one third of GTM taxa, decreasing
the richness and diversity with profiles returning to re-treatment
states for most taxa 4 weeks after the end of treatment [35].
In the current investigation, we have utilized six strains of highly
inbred experimental mice, which, through considerable genetic
relatedness between siblings and amenability to environmental
manipulation, represent useful models for the evaluation of
intrinsic and extrinsic influence upon the GTM composition. In
order to study the influence of host genetics vs. environmental
influences; i) the GTMs of age- and gender-matched mice were
profiled, including isogenic murine strains maintained within
separate locations and within two different research establish-
ments; ii) relocation studies were conducted whereby immuno-
competent and severely immuno-compromised mice were moved
in order to assess the contributions of immunophenotype and
consortial-intrinsic colonization resistance and finally, iii) the
implantation of a female BDF1 mouse with embryos from two
genetically distinct mouse strains effectively differentiated between
the effects of genetic and environmental influences upon fecal
eubacterial profiles and urinary metabolites in co-gestated animals.
Better understanding of the factors that influence the stability and
composition of the murine GTM is likely to have significant
implications for use of experimental animal models but may also
be of fundamental importance in terms of general understating of
the development and composition of mammalian (and thus
human) GTMs.
Results and Discussion
The composition and activities of the mammalian GTM
significantly influences host physiology including immune function
[36],adiposity [9,37] anddrugmetabolism[7]. Whilstthese processes
fundamentally affect the animal and human health, they may also
represent important and largely overlooked variables when designing
animal experiments and interpreting associated data. In the current
investigation, the hypothesis that murine GTM composition and
metabolism is dictated principally by genetic factors was tested using
various highly inbred mouse strains and a reproducible DNA
fingerprinting technique (PCR-DGGE), combined with quantitative
PCR and urinary metabolite analyses for compositional and
metabolic analyses, respectively. Uniquely, embryos of two distinct
strains of mice (C57 and Agoutie) were surgically implanted into a
Gut Microbiota Variation
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be investigated within different genetically distinct strains of mice
under essentially identical environments.
Better understanding of strain and location-dependant variation
in murine GTMs has obvious implications for the use of animals as
experimental models. Additionally, however fecal material from
the highly inbred mouse strains can be used to represent paradigm
vertebrate microbiotas which could provide fundamental insights
into factors influencing the development and maintenance of
GTMs.
Inter-strain variation in GTM profiles
Cluster analysis of fecal denaturing gradient gel electrophoresis
(DGGE)-derived microbial fingerprints was used to compare the
GTMs of mature female mice from the following mouse strains:
C3H, C57, GFEC, CD1, CBA nu/nu, and SCID, which were
selected as paradigm genetically distinct mice. The use of CBA
nu/nu and SCID mice additionally enabled specific immune-
impairment to be studied since these animals lack T cells and T
and B cells, respectively. GTM fingerprints from replicate (n=
3–6) animals, housed at the University of Manchester (designated
environment A) clustered together, based on mouse strain with
inter-strain concordance, ranging from 71 to 100% and intra-
strain concordance between 50 and 55% (Fig. 1). This
observation was largely corroborated by quantitative PCR
(Table 1) where inter-strain variation was apparent, particularly
for total fusobacteria, bifidobacteria and lactobacilli. Importantly,
quantitative PCR analysis showed variation in numbers of
organisms present in individual mice of the same strain were
not significant for 37/49 values (Table 1). Animals were also
shown to retain a highly stable, mature GTM over time (Fig. 2).
Whilst these data were suggestive of genetic determination of
GTM profiles, further analyses was necessary to differentiate
between environmental and genetic factors, since individual
mouse strains were housed together with like strains and familial
GTM profiles could be perpetuated through maternal contact
and by coprophagia.
Effect of relocation on murine GTMs
The immune system of rodents is considered immature at four
weeks of age, reaching maturity by approximately 8 weeks [38]. In
order to investigate the stability of GTMs, the effect of
environmental change was studied in highly immunocompromised
SCID mice; selected from a line that had been bred and
maintained in the same unit within the University of Manchester
(environment A) for 6 years. These animals were relocated to an
alternative room (environment B) within the same institution at 8
weeks of age (n=3). Age-matched animals were also maintained in
their original environment. All animals underwent changes in
GTM profiles between 4 and 8 weeks of age but at maturity, the
GTMs of relocated animals did not markedly differ from those
that had not been moved (Fig 3). This experiment was also
repeated for C3H mice with the elaboration that animals were
relocated at either c. 4 or 8 weeks of age. This resulted in marked
changes in GTM profiles that were only manifested in immature
Figure 1. Strain-dependent clustering of mouse GTMs. UPGMA
cluster analysis of fecal DGGE profiles from six genetically distinct
strains of mice. Acronyms refer to mouse strain. All samples originated
from distinct mice.
doi:10.1371/journal.pone.0008584.g001
Table 1. 16S rRNA copy numbers of selected classes of intestinal bacteria in the feces of different strains of mice.
Mouse strain
Total
bacteroidetes
Total
enterobacteriaceae
Clostridium
perfringens
Total
bifidobacteria
Total
lactobacilli
Total
fusobacteria
Total
enterococci
GFEC 10.17 (1.14)
b 6.24 (2.41)
c,f 7.30 (0.48)
d,f,g 1.74 (1.64)
b,c,g *8.63 (2.37)
c,d,e,f *7.93 (6.89)
c,d,f *3.39 (1.13)
f
C57 11.93 (1.15)
a,d,e,f *5.61 (2.35)
f 7.47 (0.05)
d,f,g *6.52 (3.15)
a,c,d,e,f 10.08 (1.11)
d,e,f 3.10 (0.94)
c,d,e *3.82 (1.33)
f
CD1 10.43 (0.48)
d,e,f 4.51 (2.08)
a,g 6.91 (0.88)
d,f 0.87 (0.59)
a,b,d,e,f 10.67 (1.90)
a,d,e,f 1.73 (0.57)
a,b,f,g 3.32 (0.70)
f
CBA 9.56 (0.12)
b,c,g 4.05 (0.25) 5.54 (0.99)
a,b,c,e 1.38 (0.58)
b,c,g 5.00 (1.17)
a,b,c,g 0.91 (0.58)
a,b,e,g *2.67 (1.33)
g
SCID *8.60 (2.05)
b,c,g 5.89 (2.75)
f 6.94 (0.67)
d,f 1.50 (1.18)
b,c,g 5.03 (0.59)
a,b,c,g 3.39 (1.98)
c,d,f 2.86 (0.27)
f
C3H (Manchester) 9.42 (0.51)
b,c,g 3.45 (0.54)
a,b,e,g 5.08 (0.28)
a,b,c,e,g *2.81 (1.37)
b,c 4.78 (1.00)
a,b,c,g *0.45 (1.12)
a,b,e,g 2.27 (0.28)
a,b,c,e,g
C3H (Stanford) 10.86 (0.81)
d,e,f *5.91 (1.92)
c,f 6.28 (1.33)
a,b,f 4.49 (1.51)
a,c,d,e 8.96 (0.83)
d,e,f *4.60 (4.54)
c,d,f 3.63 (0.66)
d,f
Data are mean values of log10 copy numbers/g feces (animals, n=3; technical replicates n=3). Numbers in parenthesis are standard deviation values. Superscript letters
denote statistically significant differences (p,0.01) between mouse strains; a: GFEC; b: C57; c: CD1; d: CBA; e: SCID f: Manchester C3H; and g: Stanford C3H. *Denotes
significant differences within replicate animals of the same strain.
doi:10.1371/journal.pone.0008584.t001
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these animals (Fig. 4a). Additionally, urinary metabolite profiles for
C3H mice moved at 8 weeks of age and those that remained in the
original environment clustered together and were distinct from
those moved at four weeks of age, thus corroborating the DGGE
data (Fig 4b). Examination of the UPLC-MS data revealed a
complex pattern of ions/metabolites increasing or decreasing in
intensity in the group relocated at four weeks of age compared to
those in the other two groups indicating a difference in metabolite
patterns between the two groups. Confirmation of the character-
istic GTM profiles associated with each animal, together with high
degrees of microbiota stability of mature animals suggested a
possible role for host-specific factors but could also be attributed to
colonization-resistance of mature GTMs, resulting in the age-
dependant variations in the influence of environmental change. It
was therefore, necessary to more effectively differentiate between
environment and genetic factors in order to better differentiate
between these variables.
GTM development in genetically distinct, uterine-
implanted mice
In order to broadly determine the relative contribution of the
environment on GTM microbial diversity, an experiment was
carried out whereby a female BDF1 was implanted with three
Agouti (Ag) and three C57 embryos. Fecal samples were collected
from the offspring and mother at weekly intervals following
weaning (3 weeks of age) until 10 weeks of age. Fostered,
genetically distinct progeny (Ag and C57) could not be
differentiated from the BDF1 mother based on GTM fingerprints
(Fig. 5a), with dendrogram concordance of in excess of 93%.
Furthermore, metabonomic analysis of urine samples from these
animals indicated that whilst animals could be differentiated based
on their gender, mouse genotype was not an effective differentiator
(Fig. 5b). Concordance within GTM bacterial profiles was
therefore also manifested metabolically. These observations
suggest that environment is a dominant influence upon the
GTM profiles since progeny would otherwise have maintained
strain-specific GTM profiles.
Murine GTMs of isogenic mice from distinct research
centers
In order to examine the practical implications of the purported
major influence of environment upon GTM profiles and for
corroboration, feces from C3H mice obtained from Stanford
University and The University of Manchester breeding houses was
subjected to PCR-DGGE and cluster analysis. Data generated in
this manner indicated that mice from the Manchester breeding
house had substantially different GTM profiles from C3H mice at
Stanford University (c. 60% concordance for Manchester vs.
Stanford compared to .80% inter-strain concordance; Figure 6)
Figure 2. Temporal GTM stability within a single C57 strain
mouse sampled over a 30-month period. (UPGMA cluster analysis
of fecal DGGE profiles).
doi:10.1371/journal.pone.0008584.g002
Figure 3. Effect of relocation on the GTM profiles of highly
immunocompromised SCID mice (UPGMA cluster analysis of
fecal DGGE profiles). All animals were housed in environment A
until 8 weeks of age. Samples obtained during this period are
designated by blue symbols. Red symbols represent fecal samples
obtained from animals that remained in the original environment (A)
(sampled in the animals over 8 weeks of age); open symbols
represent animals relocated to environment B. Numbers indentify
individual animals; numbers in parenthesis give the age of animal in
weeks.
doi:10.1371/journal.pone.0008584.g003
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Stanford C3H breeding colonies originated from the same source,
having been gifted by the National Institutes of Health in 1947 but
over time, unique GTMs appear to have developed in the
individual colonies, probably because of because consortial drift
and distinct local environmental conditions.
Conclusions
The major roleof the GTM in the metabolism of dietaryresidues
and xenobiotics [7] and its associated influence of host physiology
and metabolism [9,14] means that marked variation within GTMs
between research institutions, which is apparently more strongly
influenced by the environment than by host genotype, has
implications for many areas of research. Animal models are
currently used to assess the pharmacokinetics, metabolism and
toxicology of new drugs etc. Differences in GTMs associated with
the maintenance of animals within distinct research centers could
have obvious, but to date, poorly understood effects on experi-
mental outcomes. Such variation may for example, significantly
influence drug metabolism within apparently identical mouse
strains [5]. Specific metabonomic studies have shown that
individual, pre-dose urinary metabolic phenotypes (which are
strongly influenced by the microbiota [39] can be used to predict
the metabolic fate and toxicity of drugs and other xenobiotics in
animals [8] and the urinary metabolic phenotype of human
volunteers was recently found to predict the metabolic fate of
acetaminophen (paracetamol) based on the quantity of urinary p-
cresol, a product of gut microbial metabolism [40,41].
Whilst other reports have suggested that host genetics are
primarily responsible for the composition of the GTM in humans
and animals [6,29] some of these have utilized fraternal and
identical human twins and sibling groups. Whilst such approaches
are laudable, differentiation between environmental and genetic
factors remains a problem. Other investigations have however,
indicated a complex interplay between genetics and environment.
For example, a study involving reciprocal transplantations of
GTMs between germ-free zebra fish and mice has indicated that
host-factors are involved in the selection of GTM profiles which,
although resembling those of the donor animal with respect to
bacterial lineages, assumed relative abundances more closely
resembling the normal GTM profile of the recipient host [42].
Another key investigation used a comprehensive, network-based
analysis of fecal 16S rRNA genes sequences from humans but also
from 59 other mammalian species to elucidate major influences
such as diet and host phylogeny upon the GTM composition and
to gain insight into the likely evolution of such associations [43].
GTM communities were more similar between conspecific hosts
than between different species and when conspecific hosts lived
separately, significant clustering was still apparent in some (for
example, between two baboons living on different continents; one
in the wild, one in captivity), but not all cases. Highly significant
clustering was also apparent according to diet which could be
analysed as a variable independently of host phylogeny. Interper-
sonal differences between humans appeared to be lower than
differences between distinct mammalian species.
In the current study, the use of animal models has suggested that
the environment is a major factor in the determination of the
GTM profiles of mice. This is evidenced by the apparent strain-
dependence of GTM compositional and metabolic profiles, which
were absent when genetically distinct mice were gestated and
Figure 4. Age-dependent effects of relocation on the GTM profiles and urinary metabolite profiles of C3H mice. (a) UPGMA cluster
analysis of fecal DGGE profiles. Blue symbols represent fecal samples obtained from animals housed in the original environment (A). Samples
obtained from mice relocated at 4 weeks of age are represented by open symbols; red symbols represent animals relocated to environment B at over
8 weeks of age. Numbers identify individual animals; numbers in parenthesis give the age of animal in weeks and (b) UPLC-MS PCA results from the
analysis of urine samples from these animals showing the effect of relocation on metabolite profiles.
doi:10.1371/journal.pone.0008584.g004
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mice derived from different research institutions. From a practical
perspective, differences in GTM profiles and metabolism within
putatively isogenic mice could result in significant unforeseen
variation in the effects of drug treatment in experimental animals
and ultimately in humans.
Materials and Methods
Ethics
All procedures used in this study incorporated the 1998 United
Kingdom Coordinating Committee on Cancer Research Guide-
lines and were in compliance with The Scientific Procedures Act
of 1986. Studies were approved by the Home Office Inspectorate
and the University of Manchester Ethics Care Committee under
PPL 40/2328. Animals were maintained using the highest possible
standard of care and priority was given to their welfare above
experimental demands at all times.
Mouse strains
All mice used within this study were housed within the
University of Manchester animal facilities. Mouse strains used in
the work were: C3H, C57BL6, Agouti (C57BL66BALB/C),
GFEC (A transgenic mouse on a C57BL6 background, engineered
to express GFP tagged glial fibrillary acidic protein), BDF1
(C57BL66DBA2, [B-cell deficient] used for super ovulation and
embryo implantation), CBA nu/nu and CD-1 nu/nu (both T-cell
deficient), and SCID mice (T- and B-cell deficient). All strains are
bred in-house with the exception of the C57, CD-1 nu/nu and
SCID mice that were purchased at .4 weeks old from Charles
River, UK.
Murine relocation studies
Mature Mice (n=6) from two distinct strains (C3H and CBA –
in total twelve mice) were selected for this experiment. The mice
were divided into two groups (n=3 in each group) and identified
by means of ear tagging. One group of mice were relocated to
environment B (quarantine area of another animal house) upon
reaching maturity (8 weeks of age), whilst the other group
remained in the original breeding environment (environment A).
Fecal samples were collected weekly from all individuals and
subjected to 16S PCR-DGGE. Fingerprints were sorted using
cluster analysis. Mice were transported and housed in individual
autoclaved housing units within the quarantine area of environ-
ment B, and fed the same autoclaved food. This was repeated from
immature animals whereby mice (n=3) of two genetically distinct
strains (C3H and CBA – total 6 mice) were selected for the
experiment. Upon weaning (4 weeks of age), all mice were moved
to environment B. In all cases, fecal samples and urine were
collected weekly from all individuals and archived at 270 for
subsequent analysis.
Implantation of genetically distinct mouse embryos
Agoutie and C57 mouse embryos at the blastocyte stage were
implanted into a pseudo-pregnant BDF1 strain mother. Mice were
born naturally and allowed to remain with the surrogate mother
until weaning. At this stage the mother was removed and sacrificed
for health screening. One fecal sample was collected from the
Figure 5. GTM development in genetically distinct, uterine-implanted mice. (a) UPGMA cluster analysis of fecal DGGE profiles; (b) PCA score
plot of the two first PCs of analysis of UPLC-MS urine analysis data set (gender is indicated). The model describes 82% of the variation. Urinary
metabolite profiles cluster on the basis of gender (blue cluster boundary, males; pink cluster boundary, females) but not genotype. C57 (blue
triangles) and Agoutie; AG (red diamonds) gestated in a BDF1 strain mother (green cross).
doi:10.1371/journal.pone.0008584.g005
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collected from the offspring from weaning until nine weeks of age.
PCR-Denaturing Gradient Gel Electrophoresis (DGGE) of
fecal samples
Fecal samples were collected from individual mice directly into
a sterile Eppendorf tubes, weekly from 4 weeks of age. Samples
were then frozen within 2 hours of receipt. DNA was extracted
using a Qiagen stool mini DNA extraction kit (Qiagen, Sussex,
UK) with the added step of using a mini bead beater to
homogenize the sample. Glass beads were added to the feces with
sterile buffer (provided in Qiagen kit) and mixed for 90s. The
amount and quality of DNA extracted was estimated by
electrophoresis of 5-ml aliquots on a 0.8% agarose gel and
comparison to a molecular weight standard (stained with ethidium
bromide). DNA extracts were stored at 260uC prior to analysis in
nuclease-free containers.
The V2-V3 region of the 16S rRNA gene (corresponding to
positions 339 to 539 of Escherichia coli) was amplified with
eubacterium-specific primers HDA1-GC (59-CGC CCG GGG
CGC GCC CCG GGC GGG GCG GGG GCA CGG GGG
GAC TCC TAC GGG AGG CAG CAG T-39) and HDA2 (59-
GTATTA CCG CGG CTG CTG GCA C-39) as previously
described (40). The reactions were performed in 0.2-ml tubes
with a DNA thermal cycler (model 480; Perkin-Elmer, Cam-
bridge, United Kingdom). In all cases, reactions were carried out
with Red Taq DNA polymerase ready mix (25 ml; Sigma, Poole,
Dorset, United Kingdom), HDA primers (2 ml of each, 5 mM),
nanopure water (16 ml), and extracted community DNA (5 ml,
corresponding to ca.10 ng). The thermal program was 94uC
(4 min) followed by 30 thermal cycles of 94uC (30 s), 56uC (30 s),
and 68uC (60 s). The final cycle incorporated a 7-min chain
elongation step (68uC). Electrophoresis was carried out at 150 V
and 60uC for approximately 4.5 h. Gels were stained with SYBR
Gold stain [diluted to 10
24 in 16 TAE; Molecular Probes
(Europe), Leiden, The Netherlands] for 30 min. Gels were
viewed under U.V illumination and RAW images captured using
a Canon D60 DSLR camera with a 50mm macro lens with UV
filter attached.
Cluster analyses
Gel images were aligned using Adobe Photoshop 6.5 (Adobe,
CA, USA) aided by running common samples on multiple gels, to
allow comparison of more than one gel. Gel images were then
analysed using Bionumerics software (Applied Maths, Sint-
Martens Latem, Belgium). Lane boundaries were applied to gels
and images which were optimised to reduce the background noise
and smiling of lanes (where applicable). Automatically detected
bands (checked manually) were used to create matching profiles
for lanes (in relation to each other). The matching profiles for
each lane were used to produce an Unweighted Pair Group
Method with Arithmetic Mean (UPGMA) dendrogram. The
UPGMA algorithm weighs each lane being analysed equally and
computes the average similarity or dissimilarity of each lane to an
extant cluster. The dendrogram that is produced using this
method can then be used to observe clustering patterns between
different lanes.
Quantitative PCR of major groups within different strains
of mice
Fecal samples from six strains of mice (n=3 of each strain) were
subject to Q-PCR using methods as described in Bartosch et al
(2004) Primers sets, designed to specifically target lactobacilli,
Figure 6. Institution-specific GTMs in C3H mice. A UPGMA
dendrogram generated from fecal bacterial fingerprints of C3H mice
housed at within UK (University of Manchester) and USA (Stanford
University) institutes. All sample originated from distinct mice.
doi:10.1371/journal.pone.0008584.g006
Table 2. Primers used for quantitative PCR.
Primer target Amplicon size (bp) Oligonucleotide sequence (59 -3 9) Annealing temp. (uC) Reference
Bacteroides–Prevotella– Porphyromonas 140 F: GGTGTCGGCTTAAGTGCCAT
R: CGGA(C/T)GTAAGGGCCGTGC
68 Rinttila et al. [44]
Bifidobacterium spp. 243 F: TCGCGTC(C/T)GGTGTGAAAG
R: CCACATCCAGC(A/G)TCCAC
58 Rinttila et al [44]
Enterococcus spp. 144 F: CCCTTATTGTTAGTTGCCATCAT
R: ACTCGTTGTACTTCCCATTGT
61 Rinttila et al. [44]
Fusobacterium spp. 273 F: CCCTTCAGTGCCGCAGT
R: GTCGCAGGATGTCAAGAC
54 Rinttila et al. [44]
Enterobacteriaceae 195 F: CATGACGTTACCCGCAGAAGAAG
R: CTCTACGAGACTCAAGCTTGC
63 Bartosch et al. [45]
Clostridium perfringens 105 F: CGCATAACGTTGAAAGATGG
R: CCTTGGTAGGCCGTTACCC
55 Wise & Siragusa [46]
Lactobacillus group 341 F: CACCGCTACACATGGAGR:
AGCAGTAGGGAATCTTCCA
58 Martı ´nez et al. [47]
doi:10.1371/journal.pone.0008584.t002
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bifidobacteria and total bacteroidetes are given in Table 2. The
copy number per ml of the target gene was calculated for each
sample using standards of known copy numbers. Data were
analysed statistically using a one way ANOVA test to look for
significant differences in numbers of organisms between strains of
mice. ANOVA testing was also used to determine any significant
differences in numbers of organisms between individual mice of
the same strain. Copy number values were calculated using
Microsoft Excel. Data was statistically analysed using the Kruskal
Wallace statistical significance test in the Statsdirect programme
(Cheshire, UK). Mean values were logged and the standard
deviation were also calculated using Statsdirect.
Metabolic profiling
Urine samples, collected weekly and stored at 220uC were
diluted with water (1:3) and analysed by Ultra performance liquid
chromatography (Waters, USA) linked to a Q-Trap 4000 mass
spectrometer (Applied Biosystems, UK). Chromatography was
performed on an Aqcuity 10062.1 mm I.D. column (Waters,
USA) at 50uC and a flow rate of 0.4 mL/min using reversed-phase
elution with water and acetonitrile (both containing 0.1% formic
acid v/v) over 10 min. Pooled samples were prepared as quality
controls (QCs) and these were analysed between the samples. Mass
scan data data (100–850 amu) were collected in +ve and 2ve ESI
mode. The raw data were extracted with MarkerView. Multivar-
iate data analysis was performed with Simca P (Umetrics, Sweden;
Principal Components Analysis (PCA) and Orthogonal Partial
Least Squares Analysis (OPLS) were applied to project the data).
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